Deepti Kantamani
Hematology & Oncology · Columbus, GANPI 1598321598
Payments from drug & device makers
Across 137 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$447
- Daiichi Sankyo Inc.$423
- GSK$297
- AbbVie$239
- Johnson & Johnson$212
- E.r. Squibb & Sons, L.L.C.$135
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,55386%
- Education$42914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 17 | $447 |
| Daiichi Sankyo Inc. | 22 | $423 |
| GSK | 10 | $297 |
| AbbVie | 12 | $239 |
| Johnson & Johnson | 8 | $212 |
| E.r. Squibb & Sons, L.L.C. | 7 | $135 |
| Merck | 6 | $127 |
| Pfizer | 6 | $107 |
| Bristol Myers Squibb | 5 | $85 |
| Gilead | 1 | $80 |
| Astellas Pharma US Inc | 4 | $64 |
| Novartis | 3 | $61 |
| Exelixis Inc. | 3 | $60 |
| Eisai Inc. | 3 | $58 |
| Beigene USA, Inc. | 3 | $55 |
| Genentech USA, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Recordati_rare_diseases_inc. | 2 | $45 |
| Seagen Inc. | 3 | $40 |
| Sanofi | 1 | $35 |
| Secura Bio, Inc. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $34 |
| Stemline Therapeutics Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Geron Corporation | 1 | $30 |
| Sobi, Inc | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Bayer | 1 | $16 |
| Springworks Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JEMPERLI$125
How this compares
$2,982 in reported general payments places this provider in the 35th percentile of 370 hematology & oncology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NubeqaDarolutamide | 13 | $192,919 |
| Abiraterone Acetate | 27 | $52,226 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $1,154 |
| Oxycodone Hcl | 26 | $577 |
| Anastrozole | 34 | $372 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $341 |
| Ondansetron OdtOndansetron | 16 | $244 |
| Promethazine Hcl | 21 | $208 |
| Gabapentin | 14 | $168 |
| Prednisone | 24 | $156 |
| Levothyroxine Sodium | 11 | $80 |
| Potassium Chloride | 11 | $59 |
| Amlodipine Besylate | 12 | $41 |
| Levetiracetam | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerNubeqa | $16 | $192,91913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Columbus
- Mehmet BilenAtlanta$21.7M
- Steven McCuneMarietta$19.5M
- Ajay NookaAtlanta$19.3M
- Olatunji AleseAtlanta$15.5M
- Jonathon CohenAtlanta$8.7M
- Ticiana LealAtlanta$6.1M
- Amelia ZelnakCumming$4.4M
- Conor SteuerAtlanta$4.4M
- Anthony HunterAtlanta$4.3M
- Robert BrownAtlanta$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.